Related by context. Frequent words. (Click for all words.) 68 Panzem R 66 Factor VIIa 66 Meets Primary Endpoint 66 liposomal formulation 65 Initiates Phase II 64 Pivotal Trial 64 Receives Orphan Drug Designation 63 Pivotal Phase III 63 AzaSite Plus 63 MKC# 63 Commences Phase 62 Presents Positive 62 Mipomersen 62 Completes Enrollment 62 proteasome inhibitor 62 Patient Enrollment 62 topical anti infective 61 JAK inhibitor 61 Aliskiren 61 DDP# 61 Daclizumab 61 Cetrorelix 60 Initiate Phase 60 TELINTRA 60 ATHX 60 CRTX 60 phase IIb clinical 60 Kuvan R 60 Icatibant 60 Traficet EN 59 DRRX 59 Drug Candidate 59 Inc Therapeutic Competitors 59 TRANSDUR Sufentanil 59 L BLP# 59 Entereg R 59 Lubiprostone 59 Zoraxel 59 Gemzar ® 59 ACHN 59 Argatroban 59 Ambrisentan 59 GEM OS1 59 CDP# 59 Excellagen 59 R sorafenib tablets 59 Copegus R 59 DepoMed 58 FDA Clears 58 Palifosfamide 58 Allovectin 7 R 58 Benign Prostatic Hyperplasia 58 intravenous formulations 58 FDA Accepts 58 Idera Pharmaceuticals 58 elotuzumab 58 Eloxatin ® 58 KRN# 58 refractory chronic lymphocytic 58 Rebif ® 58 gets USFDA nod 58 Bone Graft 58 Trofex 58 Nasdaq VRTX 57 ALN TTR# 57 Cyclacel Pharmaceuticals 57 AUXL 57 Combidex 57 ADVENTRX Pharmaceuticals 57 orthobiologic 57 NEBIDO R 57 chemotherapy induced neutropenia 57 Thiarabine 57 NovaBay Pharmaceuticals 57 secondary hyperparathyroidism 57 Anika Therapeutics 57 Kepivance 57 Therapeutic Competitors 57 Chrysalin 57 Cyclacel Pharmaceuticals Inc. 57 Eculizumab 57 BPAX 57 Testim R 57 faropenem 57 Bicifadine 57 ISTA Pharmaceuticals 56 non alcoholic steatohepatitis 56 Nebido 56 methylnaltrexone 56 Transcept Pharmaceuticals 56 Patent Covering 56 Sunesis Pharmaceuticals 56 Genasense ® 56 BEMA Buprenorphine 56 investigational compounds 56 FENTORA 56 Pegasys ® 56 pseudobulbar affect PBA 56 Barrier Therapeutics Inc. 56 Retigabine 56 DAVANAT